There is no such thing as dispassionate cost benefit analysis (or at least, there isn't outside of a very narrow range of specific cases).
Cost benefit analysis for big complex issues like coronavirus requires the identification and quantification of things that are really difficult to identify and quantify, and there's no easy way to do that without some form of subjective value judgement.
CBA done properly is a good way to make these judgements explicit and transparent. CBA done badly is a good way to hide those judgements behind a load of figures. Neither is dispassionate.